Endoscopic bariatric and metabolic therapies for metabolic dysfunction-associated steatohepatitis: From weight loss to liver direct outcomes. Is it possible to include them as a therapeutic option?
Endoscopic bariatric and metabolic therapies for metabolic dysfunction-associated steatohepatitis: From weight loss to liver direct outcomes. Is it possible to include them as a therapeutic option?. // Best Practice & Research Clinical Gastroenterology. – URL: https://www.sciencedirect.com/science/article/pii/S1521691826000636?dgcid=rss_sd_all
Endoscopic bariatric and metabolic therapies for metabolic dysfunction-associated steatohepatitis: From weight loss to liver direct outcomes. Is it possible to include them as a therapeutic option?. Best Practice & Research Clinical Gastroenterology. https://www.sciencedirect.com/science/article/pii/S1521691826000636?dgcid=rss_sd_all
“Endoscopic bariatric and metabolic therapies for metabolic dysfunction-associated steatohepatitis: From weight loss to liver direct outcomes. Is it possible to include them as a therapeutic option?.” Best Practice & Research Clinical Gastroenterology.
@article{article37459,
title = {Endoscopic bariatric and metabolic therapies for metabolic dysfunction-associated steatohepatitis: From weight loss to liver direct outcomes. Is it possible to include them as a therapeutic option?},
journal = {Best Practice \& Research Clinical Gastroenterology},
url = {https://www.sciencedirect.com/science/article/pii/S1521691826000636?dgcid=rss_sd_all}
}